3 Results for "

PF3084014

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "PF3084014" in MCE Product Catalog:

15
15 Cited Publications
Cat. No.: HY-15185
CAS No.: 1290543-63-3
Purity:  99.78%
Synonyms: PF-3084014
Target:  

γ-secretase Apoptosis

Research Areas:  

Neurological Disease Cancer

Nirogacestat (PF-3084014) is a reversible, orally bioavailable, noncompetitive, and selective γ-secretase inhibitor with an IC50 of 6.2 nM. Inhibition of Notch signaling by Nirogacestat while minimizing gastrointestinal toxicity presents a promising approach for research of Notch receptor-dependent cancers .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-15185B
CAS No.: 1962925-29-6
Purity:  99.63%
Synonyms: PF-3084014 dihydrobromide; PF-03084014 dihydrobromide
Target:  

γ-secretase Apoptosis

Research Areas:  

Cancer

Nirogacestat dihydrobromide (PF-3084014 dihydrobromide) is a reversible, orally bioavailable, noncompetitive, and selective γ-secretase inhibitor with an IC50 of 6.2 nM. Inhibition of Notch signaling by Nirogacestat dihydrobromide while minimizing gastrointestinal toxicity presents a promising approach for research of Notch receptor-dependent cancers .
loading...
    loading...
Cat. No.: HY-15185R
CAS No.: 1290543-63-3
Synonyms: PF-3084014 (Standard)
Research Areas:  

Cancer

Nirogacestat (Standard) is the analytical standard of Nirogacestat. This product is intended for research and analytical applications. Nirogacestat (PF-3084014) is a reversible, orally bioavailable, noncompetitive, and selective γ-secretase inhibitor with an IC50 of 6.2 nM. Inhibition of Notch signaling by Nirogacestat while minimizing gastrointestinal toxicity presents a promising approach for research of Notch receptor-dependent cancers .
loading...
    loading...